TRIFAROTENE

TRIFAROTENE was reported 183 times

TRIFAROTENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWEAT GLAND EXCISION 1 0.0435
1 APPLICATION SITE FISSURE 2 0.0222
2 FALLOPIAN TUBE OBSTRUCTION 1 0.0143
3 DILATED PORES 1 0.0110
4 INTRACRANIAL INFECTION 1 0.0080
5 OVARIAN GERM CELL TERATOMA BENIGN 1 0.0071
6 ADNEXAL TORSION 2 0.0063
7 ADNEXA UTERI CYST 1 0.0062
8 ACNE FULMINANS 1 0.0051
9 CAVERNOUS SINUS THROMBOSIS 1 0.0039
10 CENTRAL HYPOTHYROIDISM 1 0.0030
11 CEREBRAL MASS EFFECT 1 0.0028
12 ESSENTIAL THROMBOCYTHAEMIA 1 0.0027
13 SUPRAPUBIC PAIN 1 0.0020
14 ARTERITIS 1 0.0016
15 APPLICATION SITE ULCER 1 0.0014
16 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
17 SEPTIC EMBOLUS 1 0.0012
18 PERIORBITAL PAIN 1 0.0012
19 MYDRIASIS 15 0.0012
20 SKIN HYPERPIGMENTATION 9 0.0010
21 SKIN TEXTURE ABNORMAL 1 0.0010
22 APPLICATION SITE EXFOLIATION 4 0.0010
23 CONSCIOUSNESS FLUCTUATING 1 0.0010
24 INTENTIONAL UNDERDOSE 7 0.0010
25 OEDEMA MUCOSAL 1 0.0010
26 OPTIC NERVE INJURY 1 0.0009
27 PUSTULE 2 0.0008
28 NASAL PRURITUS 1 0.0008
29 CHEMICAL BURN OF SKIN 2 0.0008
30 APPLICATION SITE EROSION 1 0.0008
31 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
32 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
33 INFECTIOUS PLEURAL EFFUSION 1 0.0007
34 OPHTHALMOPLEGIA 1 0.0006
35 ANTICHOLINERGIC SYNDROME 1 0.0006
36 APPLICATION SITE BURN 3 0.0006
37 SEBORRHOEIC DERMATITIS 1 0.0006
38 APPLICATION SITE DRYNESS 2 0.0006
39 PRODUCT CONTAINER ISSUE 5 0.0006
40 SEBORRHOEA 2 0.0005
41 CLEFT PALATE 1 0.0005
42 APPLICATION SITE DISCOLOURATION 2 0.0005
43 SKIN INDURATION 1 0.0005
44 URINARY RETENTION 16 0.0005
45 LUNG ABSCESS 1 0.0005
46 EXOPHTHALMOS 1 0.0005
47 APPLICATION SITE SCAB 1 0.0005
48 DANDRUFF 1 0.0005
49 PARESIS 1 0.0004
50 DERMATITIS CONTACT 5 0.0004
51 ROSACEA 2 0.0004
52 RETINAL TEAR 1 0.0004
53 DERMATOMYOSITIS 1 0.0004
54 LIPOMA 1 0.0004
55 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
56 SKIN DISCOMFORT 1 0.0004
57 PERIORBITAL SWELLING 2 0.0004
58 SKIN WARM 2 0.0003
59 PAIN OF SKIN 9 0.0003
60 ACNE CYSTIC 1 0.0003
61 SKIN IRRITATION 13 0.0003
62 SKIN WEEPING 1 0.0003
63 FACIAL BONES FRACTURE 1 0.0003
64 APPLICATION SITE PAIN 6 0.0003
65 SENSITIVE SKIN 2 0.0003
66 SCAB 3 0.0003
67 MICTURITION URGENCY 3 0.0003
68 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
69 VENOUS THROMBOSIS 1 0.0003
70 POLYDIPSIA 1 0.0003
71 ARTHRITIS BACTERIAL 1 0.0002
72 DERMATITIS 5 0.0002
73 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
74 SKIN BURNING SENSATION 17 0.0002
75 PURULENT DISCHARGE 1 0.0002
76 PRODUCT DISPENSING ISSUE 1 0.0002
77 APPLICATION SITE ERYTHEMA 6 0.0002
78 ACNE 17 0.0002
79 IRON DEFICIENCY 1 0.0002
80 PHARYNGEAL SWELLING 2 0.0002
81 GINGIVITIS 1 0.0002
82 TYPE 1 DIABETES MELLITUS 1 0.0002
83 SKIN EXFOLIATION 14 0.0002
84 APPLICATION SITE IRRITATION 2 0.0002
85 SOMNAMBULISM 1 0.0002
86 ULCER HAEMORRHAGE 1 0.0001
87 PANIC REACTION 1 0.0001
88 ERYTHEMA 28 0.0001
89 SUNBURN 1 0.0001
90 RASH PAPULAR 3 0.0001
91 LIVER INJURY 3 0.0001
92 PHOTOSENSITIVITY REACTION 2 0.0001
93 ATRIAL SEPTAL DEFECT 1 0.0001
94 SENSATION OF FOREIGN BODY 1 0.0001
95 SKIN SWELLING 1 0.0001
96 RASH MACULAR 4 0.0001
97 DRY SKIN 15 0.0001
98 LIP DRY 1 0.0001
99 EYE INFLAMMATION 1 0.0001
100 AFFECT LABILITY 1 0.0001
101 SPINAL FRACTURE 2 0.0001
102 MOTOR DYSFUNCTION 1 0.0001
103 TOOTH DISORDER 2 0.0001
104 FISTULA 1 0.0001
105 MADAROSIS 1 0.0001
106 CYST 1 0.0001
107 DERMATITIS ATOPIC 4 0.0001
108 DYSMENORRHOEA 1 0.0001
109 IMPAIRED GASTRIC EMPTYING 1 0.0001
110 VISION BLURRED 10 0.0001
111 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
112 BLINDNESS UNILATERAL 1 0.0001
113 DYSSTASIA 2 0.0001
114 LACRIMATION INCREASED 2 0.0001
115 SKIN DISCOLOURATION 3 0.0001
116 SCAR 1 0.0001
117 INTENTIONAL PRODUCT MISUSE 5 0.0001
118 HEAD DISCOMFORT 1 0.0001
119 UNDERDOSE 4 0.0001
120 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
121 DYSURIA 2 0.0001
122 CONJUNCTIVITIS 1 0.0001
123 SKIN FISSURES 1 0.0001
124 SINUS DISORDER 1 0.0001
125 DISCOMFORT 3 0.0000
126 RIB FRACTURE 1 0.0000
127 ROAD TRAFFIC ACCIDENT 2 0.0000
128 EATING DISORDER 1 0.0000
129 SWELLING FACE 3 0.0000
130 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
131 SNEEZING 1 0.0000
132 APPLICATION SITE PRURITUS 1 0.0000
133 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
134 PRODUCT PRESCRIBING ERROR 1 0.0000
135 RASH ERYTHEMATOUS 2 0.0000
136 DIABETIC KETOACIDOSIS 1 0.0000
137 CEREBRAL INFARCTION 1 0.0000
138 DRY EYE 2 0.0000
139 HAEMATEMESIS 1 0.0000
140 GASTRITIS 1 0.0000
141 DRUG INTERACTION 6 0.0000
142 JAUNDICE 1 0.0000
143 BLOOD BILIRUBIN INCREASED 1 0.0000
144 THROAT TIGHTNESS 1 0.0000
145 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
146 TREATMENT FAILURE 3 0.0000
147 EYE PAIN 2 0.0000
148 INTENTIONAL DOSE OMISSION 1 0.0000
149 LIVER FUNCTION TEST ABNORMAL 1 0.0000
150 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
151 NASAL CONGESTION 2 0.0000
152 URINARY INCONTINENCE 1 0.0000
153 OROPHARYNGEAL PAIN 3 0.0000
154 HYPERSENSITIVITY 6 0.0000
155 SWOLLEN TONGUE 1 0.0000
156 EYE DISORDER 1 0.0000
157 VIRAL INFECTION 1 0.0000
158 LIP SWELLING 1 0.0000
159 FUNGAL INFECTION 1 0.0000
160 GAIT INABILITY 1 0.0000
161 TOXICITY TO VARIOUS AGENTS 5 0.0000
162 GASTRIC DISORDER 1 0.0000
163 NIGHTMARE 1 0.0000
164 LYMPHADENOPATHY 1 0.0000
165 CRYING 1 0.0000
166 ACCIDENTAL OVERDOSE 1 0.0000
167 EYE SWELLING 1 0.0000
168 DISORIENTATION 1 0.0000
169 EXTRA DOSE ADMINISTERED 1 0.0000
170 DEVICE DISLOCATION 1 0.0000
171 COLITIS ULCERATIVE 1 0.0000
172 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
173 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
174 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
175 CELLULITIS 1 0.0000
176 THERAPY CESSATION 1 0.0000
177 ABDOMINAL PAIN UPPER 4 0.0000
178 ABDOMINAL DISTENSION 2 0.0000
179 OEDEMA 1 0.0000
180 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
181 PRURITUS 7 0.0000
182 HAEMATOCHEZIA 1 0.0000
183 BLISTER 1 0.0000
184 EYE IRRITATION 1 0.0000
185 PRODUCT SUBSTITUTION ISSUE 1 0.0000
186 BONE PAIN 1 0.0000
187 PRODUCT DOSE OMISSION ISSUE 5 0.0000
188 IRRITABILITY 1 0.0000
189 EXPOSURE DURING PREGNANCY 1 0.0000
190 INTENTIONAL OVERDOSE 1 0.0000
191 RHINORRHOEA 1 0.0000
192 AMNESIA 1 0.0000
193 SOMNOLENCE 3 0.0000
194 MEMORY IMPAIRMENT 2 0.0000
195 BURNING SENSATION 1 0.0000
196 ANXIETY 4 0.0000
197 OFF LABEL USE 12 0.0000
198 EPISTAXIS 1 0.0000
199 INJECTION SITE BRUISING 1 0.0000
200 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
201 DRY MOUTH 1 0.0000
202 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
203 INFLUENZA LIKE ILLNESS 1 0.0000
204 BALANCE DISORDER 1 0.0000
205 RASH 5 0.0000
206 MUSCULOSKELETAL STIFFNESS 1 0.0000
207 MALAISE 5 0.0000
208 NASOPHARYNGITIS 2 0.0000
209 COUGH 3 0.0000
210 MIGRAINE 1 0.0000
211 GAIT DISTURBANCE 2 0.0000
212 DYSPEPSIA 1 0.0000
213 HEADACHE 6 0.0000
214 HAEMORRHAGE 1 0.0000
215 FALL 3 0.0000
216 INFLUENZA 1 0.0000
217 WEIGHT INCREASED 2 0.0000
218 DEPRESSION 2 0.0000
219 BACK PAIN 2 0.0000
220 PALPITATIONS 1 0.0000
221 DRUG INEFFECTIVE 11 0.0000
222 PSORIASIS 1 0.0000
223 ARTHRALGIA 3 0.0000
224 PAIN IN EXTREMITY 2 0.0000
225 CONDITION AGGRAVATED 2 0.0000
226 PAIN 4 0.0000
227 PNEUMONIA 2 0.0000
228 TREMOR 1 0.0000
229 URTICARIA 1 0.0000
230 ABDOMINAL DISCOMFORT 1 0.0000
231 MYALGIA 1 0.0000
232 URINARY TRACT INFECTION 1 0.0000
233 PYREXIA 2 0.0000
234 MYOCARDIAL INFARCTION 1 0.0000
235 COVID-19 1 0.0000
236 HYPERTENSION 1 0.0000
237 OVERDOSE 1 0.0000
238 CONSTIPATION 1 0.0000
239 DECREASED APPETITE 1 0.0000
240 ABDOMINAL PAIN 1 0.0000
241 FEELING ABNORMAL 1 0.0000
242 DIZZINESS 2 0.0000
243 FATIGUE 3 0.0000
244 INSOMNIA 1 0.0000
245 DYSPNOEA 2 0.0000
246 INJECTION SITE PAIN 1 0.0000
247 ASTHENIA 1 0.0000
248 NAUSEA 2 0.0000
249 DEATH 1 0.0000